Personalis Inc
NASDAQ:PSNL
Relative Value
The Relative Value of one PSNL stock under the Base Case scenario is 5.19 USD. Compared to the current market price of 1.58 USD, Personalis Inc is Undervalued by 70%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
PSNL Competitors Multiples
Personalis Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Personalis Inc
NASDAQ:PSNL
|
79.8m USD | 1.1 | -0.7 | 0.4 | 0.3 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.5B USD | 5.2 | 36.9 | 22.8 | 33.4 | ||
US |
Danaher Corp
NYSE:DHR
|
184.2B USD | 4.2 | 22.8 | 16.6 | 20.5 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.6B USD | 2.8 | 30.6 | 16.7 | 25.7 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.5B CHF | 5.6 | 57.4 | 19.7 | 28.9 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
56.4T KRW | 15.3 | 65.7 | 34.7 | 49.9 | ||
US |
Agilent Technologies Inc
NYSE:A
|
41.4B USD | 6.1 | 33.5 | 26.8 | 32.2 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.9B USD | 9.2 | 47.3 | 32.8 | 39.8 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.1 | 23.8 | 26.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26B USD | 3.2 | 38.1 | 17.2 | 26.4 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.3 | 32.4 | 53.2 |